Leadership Changes at Novo Nordisk: A Strategic Move
Published on: Feb. 3, 2026, 11:42 p.m. | Source: Devdiscourse
Novo Nordisk has appointed Jamey Millar as the head of its U.S. business and Hong Chow as head of product and portfolio strategy. Millar, previously with UnitedHealth, will assume his role in February, while Chow, coming from Merck, will start later that month.
